BOBÌåÓý

Sihong Song, Ph.D., an assistant professor in the department of pharmaceutics, has received a two-year grant for $363,750 from the National Institutes of Health’s National Heart, Lung, Blood Institute. His research goal is to develop a gene therapy approach to correct the mutation of the alpha 1 antitrypsin gene for treatment of lung and liver diseases associated with AAT gene deficiency.